{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:29:18Z","timestamp":1788236958226,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1053\/j.gastro.2019.10.038","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T23:06:07Z","timestamp":1573254367000},"page":"679-692.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin \u03b13\u03b21 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells"],"prefix":"10.1053","volume":"158","author":[{"given":"Mingyang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3265-161X","authenticated-orcid":false,"given":"Jingxuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxiang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0370-7450","authenticated-orcid":false,"given":"Zhibo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kar-Ming A.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barish H.","family":"Edil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell G.","family":"Postier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Bronze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin E.","family":"Fernandez-Zapico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7866-3686","authenticated-orcid":false,"given":"Marc P.","family":"Stemmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Brabletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney W.","family":"Houchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3971-9130","authenticated-orcid":false,"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2019.10.038_bib1","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.gastro.2019.10.038_bib2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nrc3628","article-title":"Crossing the endothelial barrier during metastasis","volume":"13","author":"Reymond","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.gastro.2019.10.038_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4161\/15384047.2014.986967","article-title":"Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors","volume":"16","author":"Samulitis","year":"2015","journal-title":"Cancer Biol Ther"},{"issue":"10039","key":"10.1053\/j.gastro.2019.10.038_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","article-title":"Pancreatic cancer","volume":"388","author":"Kamisawa","year":"2016","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2019.10.038_bib5","first-page":"511","article-title":"Role of gemcitabine as second-line therapy after progression on FOLFIRINOX in advanced pancreatic cancer: a retrospective analysis","volume":"6","author":"da Rocha Lino","year":"2015","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1053\/j.gastro.2019.10.038_bib6","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00280-011-1613-0","article-title":"A\u00a0novel method for quantification of gemcitabine and its metabolites 2\u2032,2\u2032-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC\u2013MS\/MS: comparison with 19F NMR spectroscopy","volume":"68","author":"Bapiro","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/j.gastro.2019.10.038_bib7","first-page":"283181","article-title":"Integrin signaling in cancer cell survival and chemoresistance","volume":"2012","author":"Aoudjit","year":"2012","journal-title":"Chemother Res Pract"},{"key":"10.1053\/j.gastro.2019.10.038_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/mpa.0b013e31811f4526","article-title":"The integrin-extracellular matrix axis in pancreatic cancer","volume":"35","author":"Grzesiak","year":"2007","journal-title":"Pancreas"},{"key":"10.1053\/j.gastro.2019.10.038_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbrc.2018.09.061","article-title":"Integrin \u03b21 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110\u03b2 signaling","volume":"505","author":"Yang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.gastro.2019.10.038_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","article-title":"Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance","volume":"35","author":"Cooper","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1053\/j.gastro.2019.10.038_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10555-007-9044-4","article-title":"The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs","volume":"26","author":"Zhang","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1053\/j.gastro.2019.10.038_bib12","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1593\/neo.10576","article-title":"Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells","volume":"12","author":"Hagmann","year":"2010","journal-title":"Neoplasia"},{"key":"10.1053\/j.gastro.2019.10.038_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/j.gastro.2008.09.067","article-title":"Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer","volume":"136","author":"Farrell","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.10.038_bib14","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1245\/s10434-007-9583-5","article-title":"Development and characterization of gemcitabine-resistant pancreatic tumor cells","volume":"14","author":"Shah","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.gastro.2019.10.038_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jpba.2017.12.048","article-title":"Ultra-sensitive LC-MS\/MS method for the quantification of gemcitabine and its metabolite 2\u2032,2\u2032-difluorodeoxyuridine in human plasma for a microdose clinical trial","volume":"151","author":"van Nuland","year":"2018","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1053\/j.gastro.2019.10.038_bib16","doi-asserted-by":"crossref","first-page":"18636","DOI":"10.1073\/pnas.0709307104","article-title":"Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression","volume":"104","author":"Li","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2019.10.038_bib17","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1158\/1078-0432.CCR-09-0557","article-title":"Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts","volume":"15","author":"Li","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.gastro.2019.10.038_bib18","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/emmm.201302507","article-title":"A\u00a0novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth","volume":"5","author":"Zhang","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1053\/j.gastro.2019.10.038_bib19","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1158\/1078-0432.CCR-18-0263","article-title":"ZIP4 promotes pancreatic cancer progression by repressing ZO-1 and claudin-1 through a ZEB1-dependent transcriptional mechanism","volume":"24","author":"Liu","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.gastro.2019.10.038_bib20","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.4161\/cc.28111","article-title":"ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer","volume":"13","author":"Cui","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1053\/j.gastro.2019.10.038_bib21","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1053\/j.gastro.2018.10.026","article-title":"ZIP4 promotes muscle wasting and cachexia in mice with orthotopic pancreatic tumors by stimulating RAB27B-regulated release of extracellular vesicles from cancer cells","volume":"156","author":"Yang","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.10.038_bib22","doi-asserted-by":"crossref","first-page":"9018","DOI":"10.1021\/acs.analchem.9b01311","article-title":"Quantification of drug molecules in live single cells using the single-probe mass spectrometry technique","volume":"91","author":"Pan","year":"2019","journal-title":"Anal Chem"},{"key":"10.1053\/j.gastro.2019.10.038_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.semcancer.2015.08.004","article-title":"Alpha2beta1 integrin in cancer development and chemoresistance","volume":"35","author":"Naci","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"10.1053\/j.gastro.2019.10.038_bib24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ncb3513","article-title":"The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer","volume":"19","author":"Krebs","year":"2017","journal-title":"Nat Cell Biol"},{"key":"10.1053\/j.gastro.2019.10.038_bib25","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1158\/1078-0432.CCR-09-2405","article-title":"ZIP4 regulates pancreatic cancer cell growth by activating IL-6\/STAT3 pathway through zinc finger transcription factor CREB","volume":"16","author":"Zhang","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.gastro.2019.10.038_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1476-4598-9-217","article-title":"A\u00a0novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells","volume":"9","author":"Lin","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1053\/j.gastro.2019.10.038_bib27","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1158\/1078-0432.CCR-04-0224","article-title":"The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma","volume":"10","author":"Spratlin","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.gastro.2019.10.038_bib28","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1172\/JCI73455","article-title":"Transport properties of pancreatic cancer describe gemcitabine delivery and response","volume":"124","author":"Koay","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.gastro.2019.10.038_bib29","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbrc.2010.11.125","article-title":"Regulation of ENT1 expression and ENT1-dependent nucleoside transport by c-Jun N-terminal kinase","volume":"404","author":"Leisewitz","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.gastro.2019.10.038_bib30","first-page":"942","article-title":"SP600125, a JNK inhibitor, suppresses growth of JNK-inactive glioblastoma cells through cell-cycle G2\/M phase arrest","volume":"67","author":"Li","year":"2012","journal-title":"Pharmazie"},{"key":"10.1053\/j.gastro.2019.10.038_bib31","doi-asserted-by":"crossref","first-page":"831","DOI":"10.15252\/emmm.201404396","article-title":"ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat","volume":"7","author":"Meidhof","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1053\/j.gastro.2019.10.038_bib32","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3892\/ijo.2017.4099","article-title":"Novel crosstalk between KLF4 and ZEB1 regulates gemcitabine resistance in pancreatic ductal adenocarcinoma","volume":"51","author":"Wang","year":"2017","journal-title":"Int J Oncol"},{"key":"10.1053\/j.gastro.2019.10.038_bib33","doi-asserted-by":"crossref","first-page":"10060","DOI":"10.1038\/s41598-017-09946-z","article-title":"ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer","volume":"7","author":"Gharibi","year":"2017","journal-title":"Sci Rep"},{"key":"10.1053\/j.gastro.2019.10.038_bib34","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1073\/pnas.94.6.2356","article-title":"Downstream of Crk adaptor signaling pathway: activation of Jun kinase by v-Crk through the guanine nucleotide exchange protein C3G","volume":"94","author":"Tanaka","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2019.10.038_bib35","doi-asserted-by":"crossref","first-page":"12956","DOI":"10.1074\/jbc.M807845200","article-title":"Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling","volume":"284","author":"Zhang","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1053\/j.gastro.2019.10.038_bib36","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1172\/JCI0215468","article-title":"Integrins in invasive growth","volume":"109","author":"Brakebusch","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.gastro.2019.10.038_bib37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12957-015-0451-7","article-title":"pERK1\/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression","volume":"13","author":"Wang","year":"2015","journal-title":"World J Surg Oncol"},{"key":"10.1053\/j.gastro.2019.10.038_bib38","first-page":"258","article-title":"Targeting Notch signaling pathway to overcome drug resistance for cancer therapy","volume":"1806","author":"Wang","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.gastro.2019.10.038_bib39","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1158\/1078-0432.CCR-07-1450","article-title":"HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma","volume":"14","author":"Liau","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.gastro.2019.10.038_bib40","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbrc.2012.03.122","article-title":"DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells","volume":"421","author":"Saiki","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.gastro.2019.10.038_bib41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jphs.2015.01.006","article-title":"Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors","volume":"127","author":"Minami","year":"2015","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1053\/j.gastro.2019.10.038_bib42","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1158\/0008-5472.CAN-05-4203","article-title":"Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine","volume":"66","author":"Giovannetti","year":"2006","journal-title":"Cancer Res"},{"key":"10.1053\/j.gastro.2019.10.038_bib43","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1158\/1078-0432.CCR-07-2247","article-title":"Gemcitabine resistance in pancreatic cancer: picking the key players","volume":"14","author":"Kim","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.gastro.2019.10.038_bib44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.lungcan.2010.02.005","article-title":"The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)","volume":"70","author":"Lee","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1053\/j.gastro.2019.10.038_bib45","first-page":"1221","article-title":"Caspase activation is required for gemcitabine activity in multiple myeloma cell lines","volume":"1","author":"Nabhan","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1053\/j.gastro.2019.10.038_bib46","doi-asserted-by":"crossref","first-page":"12891","DOI":"10.1038\/s41598-017-13330-2","article-title":"Mechanistic evaluation and translational signature of gemcitabine-induced chemoresistance by quantitative phosphoproteomics analysis with iTRAQ labeling mass spectrometry","volume":"7","author":"Duan","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1053\/j.gastro.2019.10.038_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/proteomes6040045","article-title":"A\u00a0comparative quantitative LC-MS\/MS profiling analysis of human pancreatic adenocarcinoma, adjacent-normal tissue, and patient-derived tumour xenografts","volume":"6","author":"Coleman","year":"2018","journal-title":"Proteomes"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508519415291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508519415291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:26:20Z","timestamp":1758036380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508519415291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0016508519415291"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2019.10.038","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin \u03b13\u03b21 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2019.10.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the AGA Institute","name":"copyright","label":"Copyright"}]}}